Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter

Biochemical and Biophysical Research Communications

Volumn 324, Issue 4, 2004, Pages 1370-1378

  Seelan, Ratnam S ^a   Parthasarathy, Latha K ^a   Parthasarathy, Ranga N ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF LOUISVILLE SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; HeLa; IMPase 1; IMPase 2; Inositol; Lithium; SK N AS

Indexed keywords

INOSITOL MONOPHOSPHATASE 2; INOSITOL PHOSPHATE; LITHIUM; UNCLASSIFIED DRUG; LITHIUM CHLORIDE; MYO INOSITOL 1 (OR 4) MONOPHOSPHATASE; MYO-INOSITOL-1 (OR 4)-MONOPHOSPHATASE; PHOSPHATASE; TRANQUILIZER;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; DOSE RESPONSE; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VIVO STUDY; NERVE CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION; BIOSYNTHESIS; DRUG EFFECT; GENE EXPRESSION; GENETICS; HELA CELL; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; TRANSCRIPTION INITIATION SITE;

ANTIMANIC AGENTS; BASE SEQUENCE; CELL LINE; DOWN-REGULATION; GENE EXPRESSION; HELA CELLS; HUMANS; LITHIUM CHLORIDE; MOLECULAR SEQUENCE DATA; PHOSPHORIC MONOESTER HYDROLASES; PROMOTER REGIONS (GENETICS); TRANSCRIPTION INITIATION SITE;

EID: 14544301050     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.09.199     Document Type: Article

References (35)

1. L.H. Price, and G.R. Heninger Lithium in the treatment of mood disorders New Engl. J. Med. 331 1994 591 598
2. R.S. Jope Anti-bipolar therapy: mechanism of action of lithium Mol. Psychiatry 4 1999 117 128
3. J.T. Coyle, and R.S. Duman Finding the intercellular signaling pathways affected by mood disorder treatments Neuron 38 2003 157 160
4. R. Vadnal, and R. Parthasarathy myo-Inositol monophosphatase: diverse effects of lithium, carbamazepine, and valproate Neuropsychopharmacology 12 1995 277 285
5. M. Bauer, and B. Ahrens Bipolar disorder: a practical guide to drug treatment CNS Drugs 6 1995 35 42
6. A.J. Harwood, and G. Agam Search for a common mechanism of mood stabilizers Biochem. Pharmacol. 66 2003 179 189
7. R.S.B. Williams, L. Cheng, A.W. Mudge, and A. Harwood A common mechanism of action for three mood-stabilizing drugs Nature 417 2002 292 295
8. S.J. Pollack, J.R. Atack, M.R. Knowles, G. McAllister, C.I. Ragan, R. Baker, S.R. Fletcher, L.L. Iverson, and H.B. Broughton Mechanism of inositol monophosphatase, the putative target of lithium therapy Proc. Natl. Acad. Sci. USA 91 1994 5766 5770
9. J.R. Atack Inositol monophosphatase inhibitors-lithium mimetics? Med. Res. Rev. 17 1997 215 241
10. L. Parthasarathy, R.E. Vadnal, R. Parthasarathy, and C.S. Shyamala Devi Biochemical and molecular properties of lithium-sensitive myo-inositol monophosphatase Life Sci. 54 1994 1127 1142
11. L.M. Hallcher, and W.R. Sherman The effects of lithium ion and other agents on the activity of myo-inositol 1-phosphatase from bovine brain J. Biol. Chem. 255 1980 10896 10901
12. M.J. Berridge, and R.F. Irvine Inositol phosphates and cell signaling Nature 341 1989 197 205
13. M.J. Berridge, C.P. Downes, and M.R. Hanley Neural and developmental actions of lithium: a unifying hypothesis Cell 59 1989 411
14. 31P MRS Biol. Psychiatry 46 1999 1634 1641
15. B.W. Agranoff, and S.K. Fisher Inositol, lithium and the brain Psychopharmacol. Bull. 35 2001 5 18
16. L. Parthasarathy, R.S. Seelan, M.A. Wilson, R.E. Vadnal, and R.N. Parthasarathy Regional changes in rat brain inositol monophosphatase (IMPase 1) activity with chronic lithium treatment Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 2003 55 60
17. P.F. Renshaw, N.E. Joseph, and J.S. Leigh Jr. Chronic dietary lithium induces increased levels of myo-inositol-1-phosphatase activity in rat cerebral cortex homogenates Brain Res. 380 1986 401 404
18. A. Shamir, R.P. Ebstein, L. Nemanov, A. Zohar, R.H. Belmaker, and G. Agam Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy Mol. Psychiatry 3 1998 481 482
19. L. Nemanov, R.P. Ebstein, R.H. Belmaker, Y. Osher, and G. Agam Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels Int. J. Neuropsychopharmacol. 2 1999 25 29
20. N.S. Gee, C.I. Ragan, K.J. Watling, S. Aspley, R.G. Jackson, G.G. Reid, D. Gani, and J.K. Shute The purification and properties of myo-inositol monophosphatase from bovine brain Biochem. J. 249 1988 883 889
21. L. Parthasarathy, R.E. Vadnal, T.G. Ramesh, C.S. Shyamala Devi, and R. Parthasarathy myo-Inositol monophosphatase from rat testes: purification and properties Arch. Biochem. Biophys. 304 1993 94 101
22. G. Sjøholt, A.K. Gulbrandsen, R. Løvlie, J.Ø. Berle, A. Molven, and V.M. Steen A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients Mol. Psychiatry 5 2000 172 180
23. T. Yoshikawa, M. Padiguru, J.D. Karkera, M. Sharma, W.H. Berrettini, L.E. Esterling, and S.D. Detera-Wadleigh Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2) Mol. Psychiatry 5 2000 165 171
24. T. Yoshikawa, G. Turner, L.E. Esterling, A.R. Sanders, and S.D. Detera-Wadleigh A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder Mol. Psychiatry 2 1997 393 397
25. G. Sjøholt, R.P. Ebstein, R.T. Lie, J.Ø. Berle, J. Mallet, J.F. Deleuze, D.F. Levinson, C. Laurent, M. Mujahed, I. Bannoura, I. Murad, A. Molven, and V.M. Steen Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder Mol. Psychiatry 9 2004 621 629
26. I.S. Yoon, P.P. Li, K.P. Siu, J.L. Kennedy, R.G. Cooke, S.V. Parikh, and J.J. Warsh Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder Mol. Psychiatry 6 2001 678 683
27. T. Yoshikawa, M. Kikuchi, K. Saito, A. Watanabe, K. Yamada, H. Shibuya, M. Nankai, A. Kurumaji, E. Hattori, H. Ishiguro, H. Shimizu, Y. Okubo, M. Toru, and S.D. Detera-Wadleigh Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples Mol. Psychiatry 6 2000 202 210
28. F.M. Ausubel, R. Brent, R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl Current Protocols in Molecular Biology 1995 Wiley New York
29. K. Quandt, K. Frech, H. Karas, E. Wingender, and T. Werner MatInd and MatInspector: new fast and versatile tools for the detection of consensus matches in nucleotide sequence data Nucleic Acids Res. 23 1995 4878 4884
30. C.D. Mao, P. Hoang, and P.E. DiCorleto Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells J. Biol. Chem. 276 2001 26180 26188
31. L. Wang, X. Liu, and R.H. Lenox Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium J. Neurochem. 79 2001 816 825
32. G. Guan, P. Dai, and I. Shechter cDNA cloning and gene expression analysis of human myo-inositol 1-phosphate synthase Arch. Biochem. Biophys. 417 2003 251 259
33. R. Hashimoto, V. Senatorov, H. Kanai, P. Leeds, and D.M. Chuang Lithium stimulates progenitor proliferation in cultured brain neurons Neuroscience 117 2003 55 61
34. A. Shamir, G. Shaltiel, M.L. Greenberg, R.H. Belmaker, and G. Agam The effect of lithium on expression of genes for inositol biosynthetic enzymes in mouse hippocampus; a comparison with the yeast model Mol. Brain Res. 115 2003 104 110
35. G. Agam, A. Shamir, G. Shaltiel, and M.L. Greenberg myo-Inositol 1-phosphate MIP synthase: a possible new target for antibipolar drugs Bipolar Disord. 4 2002 15 20